Misar Sr (Alprazolam)

Alprazolam binds to a specific site on the GABA_A receptor complex, acting as a positive allosteric modulator. This increases the opening of chloride channels when GABA binds, leading to greater neuronal inhibition and a calming effect throughout the central nervous system, which alleviates anxiety symptoms.

The appropriate dose of Misar Sr is determined by the prescribing clinician based on the individual’s medical condition, age, response to therapy, and other factors. Patients should follow the prescriber’s instructions and never adjust the dose without medical guidance.

Safety data for alprazolam in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless the potential benefit justifies the risk, and breastfeeding mothers should discuss alternatives with their healthcare provider, as the drug can be excreted in breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Misar Sr (alprazolam) is a short‑acting benzodiazepine, offering rapid onset of anxiety relief compared with longer‑acting agents such as diazepam. While effective for acute anxiety and panic attacks, its shorter half‑life may require careful dosing to avoid rebound symptoms, and it carries a higher potential for dependence than some non‑benzodiazepine alternatives.

Misar Sr should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Misar Sr is taken orally, usually with or without food, as directed by a healthcare professional. The tablets should be swallowed whole with a glass of water and not chewed, crushed, or broken unless specifically instructed by the prescriber.

Serious risks include respiratory depression, especially when combined with other central nervous system depressants, severe allergic reactions, dependence and withdrawal syndrome, and rare occurrences of seizures or severe mood changes such as depression or suicidal thoughts. Patients should seek immediate medical attention if any of these symptoms arise.

Misar Sr is contraindicated in individuals with known hypersensitivity to alprazolam or other benzodiazepines, those with acute narrow‑angle glaucoma, and patients who are currently dependent on alcohol or other central nervous system depressants. Caution is also advised for patients with severe respiratory insufficiency, severe hepatic impairment, or a history of substance abuse.